ALXO
Alx Oncology Holdings
NASDAQ: ALXO · HEALTHCARE · BIOTECHNOLOGY
$1.70
+7.59% today
Updated 2026-04-30
Market cap
$212.60M
P/E ratio
—
P/S ratio
5,085.96x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$0 – $3
Volume
1.0M
Alx Oncology Holdings (ALXO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.19M | $-14.25M | $-38.29M | $-68.10M | $-89.22M | $-130.36M | $-121.91M | $-84.14M |
| Capital expenditures | $653000.00 | $353000.00 | $31000.00 | $4.92M | $1.43M | $1.27M | $447000.00 | $212000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $269000.00 | $297000.00 | $5.44M | $13.91M | $23.84M | $26.27M | $27.09M | $12.58M |
| Free cash flow | $-13.84M | $-14.60M | $-38.32M | $-73.02M | $-90.65M | $-131.64M | $-122.36M | $-84.35M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $3000.00 | $2.75M | — | $59.68M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $425.20M | $-70.55M | $-314.78M | — | — | — |